• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,772.55(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ERIS Lifesciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 66197.0
  • ISIN : INE406M01024
1,468.20 -44 (-2.90%)
  • As on 25 Apr 2025 (EOD)

  • Today’s Low

    1,444.90

  • Today’s High

    1,512.00

  • Open

    1,512.00

  • Perv Close

    1,512.00

  • 52W Low

    815.85

  • 52W High

    1,593.90

Key Indicators

  • P/E(TTM)

    231.17

  • Mar.Cap (₹Cr.)

    19,991.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    189.25

  • Debt-Equity Ratio

    -2.90

  • AGM Date

    25-Apr-2025

  • EPS

    6.35

  • P/E Ratio

    231.17

Financials Ratios

  • Debt-Equity Ratio

    0.76

  • Mar.Cap (₹Cr.)

    19,991.39

  • RONW (%)

    16.61

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    13.62

  • BV (₹)

    189.20

  • Sales( ₹ in Cr.)

    1,528.28

  • NP (in Cr.)

    296.92

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    29.30

  • EPS (₹)

    21.80

  • Traded Value (₹ in Lakhs)

    20,579.61

  • 52 Week High

    1,593.90

  • 52 Week Low

    815.85

  • Price BSE

    1511.0

  • Price NSE

    1,512.00

  • Market Capital( in Cr.)

    20,579.61

  • P/C Ratio

    51.50

  • P/E Ratio

    69.30

  • Price Vs.BV

    21.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,528.28 1,340.37 1,215.73 1,108.83 1,020.23 896.54
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,528.28 1,340.37 1,215.73 1,108.83 1,020.23 896.54
Other Income 34.83 17.26 28.99 10.00 14.73 32.50
Stock Adjustments 13.15 -8.50 -2.49 12.57 -17.47 13.40
Total Income 1,576.26 1,349.13 1,242.23 1,131.40 1,017.49 942.44
EXPENDITURE :            
Raw Materials 293.31 227.88 197.16 211.08 146.88 145.75
Power and Fuel Cost 4.46 4.41 4.01 3.89 4.54 3.34
Employee Cost 331.67 252.52 220.11 207.02 191.73 166.77
Other Manufacturing Expenses 16.80 11.50 7.47 7.16 10.62 4.85
Selling and Administration Expenses 319.25 242.67 215.51 181.66 219.34 251.38
Miscellaneous Expenses 122.13 87.78 84.93 93.13 73.93 4.09
Employee Benefit Expenses 331.67 252.52 220.11 207.02 191.73 166.77
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,087.61 826.75 729.18 703.93 647.04 576.17
Operating Profit 488.64 522.38 513.04 427.47 370.44 366.27
Interest 57.42 20.81 3.05 0.94 1.97 22.90
Gross Profit 431.22 501.57 509.99 426.53 368.47 343.37
Depreciation 102.39 64.66 51.46 37.64 44.88 31.59
Profit Before Tax 328.83 436.91 458.53 388.89 323.59 311.78
Current Tax 57.64 76.50 80.17 70.18 57.49 68.87
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -28.52 -37.59 -38.83 -31.90 -25.17 -42.47
Reported Net Profit 299.71 398.01 417.19 350.61 291.27 285.38
Extraordinary Items 2.79 5.17 -1.72 2.33 4.49 1.08
Adjusted Net Profit 296.92 392.84 418.91 348.28 286.78 284.30
Adjustment below Net Profit -2.76 -0.15 -1.01 -1.28 -100.21 -0.10
P & L Balance brought forward 2,190.21 1,892.28 1,557.74 1,283.09 1,139.01 853.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 99.93 81.65 74.68 46.98 0.00
P & L Balance carried down 2,487.16 2,190.21 1,892.28 1,557.74 1,283.09 1,139.01
Dividend 0.00 99.93 81.65 74.68 38.97 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 735.00 601.00 550.00 287.00 0.00
Dividend Per Share(Rs) 0.00 7.35 6.01 5.50 2.87 0.00
Earnings Per Share-Unit Curr 22.03 29.27 30.69 25.82 21.45 20.75
Earnings Per Share(Adj)-Unit Curr 22.03 29.27 30.69 25.82 21.45 20.75
Book Value 185.55 163.39 141.11 116.03 95.72 84.06
Book Value(Adj)-Unit Curr 185.55 163.39 141.11 116.03 95.72 84.06

Shareholding Pattern

  • Promoter Group

    54.85%

  • Public Share Holding

    45.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,683,744 54.85 74,683,744 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 74,683,744 54.85 74,683,744 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10 0.00 10 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3 0.00 3 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,476,837 8.43 11,476,837 135
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 938,778 0.69 938,778 4
Mutual Funds / UTI 22,587,047 16.59 22,587,047 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,073,310 0.79 1,073,310 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 36,075,985 26.49 36,075,985 178
2] Non Institution
Bodies Corporate 520,660 0.38 520,660 273
Clearing Members 580 0.00 580 6
Directors of their Relatives 425 0.00 425 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 237,551 0.17 237,551 1,218
Foreign Non Institution Other 11,965,882 8.79 11,965,882 1
Hindu Undivided Families 89,012 0.07 89,012 1,015
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,033,474 6.63 9,033,474 6
Individuals holding nominal share capital up to Rs. 1 lakh 3,444,417 2.53 3,444,417 47,351
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,174 0.00 2,174 1
Others 46,585 0.03 46,585 2
Sub Total 25,402,840 18.66 25,402,840 49,904
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 136,162,569 100.00 136,162,569 50,087

Company Background

ERIS Lifesciences LtdPharmaceuticals - Indian - Formulations

  • ERIS Lifesciences Ltd
  • BSE Code : 66197.0
  • ISIN : INE406M01024

  • Incorporation Year

    2007

  • Registered Office

    8th Floor Commerce House -IV
    Prahladnagar 100 FT Road, Ahmedabad,
    Gujarat-380015

  • Telephone

    91-79-30451000

  • FAX

    91-79-48903474

  • Chairman

    Amit Indubhushan Bakshi

  • Managing Director

    Amit Indubhushan Bakshi

  • Company Secretary

    Milind Talegaonkar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

ERIS Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ERIS Lifescience 1,467.95 1,521.53 1,486.71 231.17 9.98
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92